In the BioHarmony Drug Report Database

"Preview" Icon

Darbepoetin alfa

Aranesp (darbepoetin alfa) is a protein pharmaceutical. Darbepoetin alfa was first approved as Aranesp on 2001-06-08. It is used to treat anemia in the USA. It has been approved in Europe to treat anemia, chronic kidney failure, and neoplasms.

 

Trade Name

 

Aranesp
 

Common Name

 

darbepoetin alfa
 

ChEMBL ID

 

CHEMBL1201566
 

Indication

 

anemia, chronic kidney failure, neoplasms
 

Drug Class

 

Erythropoietins

Image (chem structure or protein)

Darbepoetin alfa structure rendering